February 28, 2024

anamejia18/iStock via Getty Images

Illumina (NASDAQ:ILMN) has been one of the worst performers in the S&P Health Care Select Fund (XLV), falling 40% in 2023 alone. Illumina’s market cap has fallen from over $75 billion to just $18 billion at the time of this writing, representing